The Flow Cytometry In Oncology And Immunology Global Market Report 2023, provides comprehensive information on the flow cytometry in oncology and immunology market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Flow Cytometry In Oncology And Immunology Market’s Growth:
As per The Business Research Company’s Flow Cytometry In Oncology And Immunology Global Market Report 2023, the global flow cytometry in oncology and immunology market is expected to grow from $1.70 billion in 2022 to $1.89 billion in 2023 at a compound annual growth rate (CAGR) of 11.03%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The flow cytometry in oncology and immunology market is expected to reach $2.79 billion in 2027 at a CAGR of 10.2%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12469&type=smp
Technological advancements are a key trend gaining popularity in flow cytometry in the oncology and immunology markets. Major companies operating in flow cytometry in the oncology and immunology markets are adopting new technologies to sustain their position in the market. For instance, in September 2022, Becton Dickinson, and Company, a US-based medical technology provider, launched BD Research Cloud for flow cytometry in oncology and immunology. BD Cloud is a cloud-based software system that simplifies the flow cytometry process for researchers working in various fields, such as immunology, virology, infectious disease, and oncology surveillance, to enable higher-quality studies with quicker time to insight. BD is leveraging innovative technologies like BD Horizon RealYellow and RealBlue Reagents, as well as the newly introduced BD FACSDiscover S8 Cell Sorter with BD CellView Image Technology, to enhance the capabilities of flow cytometry, enabling researchers to optimize and advance their groundbreaking studies. Built on an industry-standard cloud infrastructure, BD Research Cloud is uniquely suited for BD equipment and reagents.
The flow cytometry in oncology and immunology market is segmented:
1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
North America was the largest region in the flow cytometry in oncology and immunology market in 2022.
The table of contents in TBRC’s flow cytometry in oncology and immunology market report includes:
- Executive Summary
- Flow Cytometry In Oncology And Immunology Market Characteristics
- Flow Cytometry In Oncology And Immunology Market Trends And Strategies
- Flow Cytometry In Oncology And Immunology Market – Macro Economic Scenario
- Global Flow Cytometry In Oncology And Immunology Market Size and Growth
.
.
.
- Global Flow Cytometry In Oncology And Immunology Market Competitive Benchmarking
- Global Flow Cytometry In Oncology And Immunology Market Competitive Dashboard
- Key Mergers And Acquisitions In The Flow Cytometry In Oncology And Immunology Market
- Flow Cytometry In Oncology And Immunology Market Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
